NEW YORK, NY--(Marketwire - Oct 17, 2012) - The global market for clinical nutrition products, at the manufacturers' level, should reach $28.4 billion in 2012, according to Kalorama Information. The healthcare market research publisher said that sales for clinical nutrition formulas increased 6.6% annually in the past four years due to expanding product lines in global markets, an aging population, increasing incidence of disease, a steady infant birth rate, recovering market conditions and several other factors. Growth from 2010 to 2012 showed the impact of the improving economic situation in the U.S. and other developed regions, according to the findings in The World Market for Clinical Nutrition Products, 5th Edition. <\/p>\n
The report breaks out the market into three product segments: enteral food consumed orally such as nutritional drinks; parenteral food served to patients through feeding tubes; and infant nutrition. The infant formula segment was a major contributor to recent growth. Sales for infant formulas have increased substantially in global markets, especially in many Eastern European, Asian, and Middle Eastern regions. Additionally, an aging population and increased awareness of the relationship between health and nutrition are driving sales for all clinical nutrition products in most regions worldwide. <\/p>\n
\"The clinical nutrition market experienced a slowdown during 2009 due to the economic downturn in many developed regions,\" said Melissa Elder, author of the report. \"Many manufacturers reported recovering sales during 2010, which continued throughout 2011 and 2012.\" <\/p>\n
Growth during the forecast period is expected to be steady, continuing at the same pace in the next four years. Developments in follow-up formulas, organic formulas, and other innovative products will drive sales throughout the forecast period. The infant segment should lead growth, according to the report. <\/p>\n
Competition in the clinical nutrition market is dominated by a handful of companies, ranging from global nutritional manufacturers to leading pharmaceutical companies. Abbott, Nestle, Fresenius Kabi, Baxter and Mead Johnson are among the key players in this market. <\/p>\n
Kalorama Information provides detailed profiles of companies in the market, a discussion of trends, and reviews of products, as well as specific market sizes by region and product type, in its full report, The World Market for Clinical Nutrition Products, 5th Edition. <\/p>\n
About Kalorama Information Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog. <\/p>\n<\/p>\n
More here: NEW YORK, NY--(Marketwire - Oct 17, 2012) - The global market for clinical nutrition products, at the manufacturers' level, should reach $28.4 billion in 2012, according to Kalorama Information. The healthcare market research publisher said that sales for clinical nutrition formulas increased 6.6% annually in the past four years due to expanding product lines in global markets, an aging population, increasing incidence of disease, a steady infant birth rate, recovering market conditions and several other factors Continue reading
\nClinical Nutrition Products Market Bounces Back From Economic Downturn<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"